Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Prelude Therapeutics (PRLD) Accumulated Depreciation & Amortization (2024 - 2025)

Prelude Therapeutics' Accumulated Depreciation & Amortization history spans 1 years, with the latest figure at $5.3 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization changed N/A year-over-year to $5.3 million; the TTM value through Dec 2024 reached $5.3 million, changed N/A, while the annual FY2024 figure was $5.3 million, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $5.3 million at Prelude Therapeutics.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.3 million in Q4 2024 and bottomed at $5.3 million in Q4 2024.